Our history

03 october 2024
Announced a major breakthrough in mRNA vaccine technology for combating emerging pandemics, showcasing significant advancements in rapid vaccine development and global distribution strategies.

16 November 2024
The company, initially called "WellHealth Laboratories," was founded in Zurich, Switzerland, by Dr. Emil Hauser, focusing on herbal remedies and natural health products.

28 December 2024
Released its first synthetic drug, "CardioRelief," for treating heart conditions, which became a global success and solidified its reputation as a reliable pharmaceutical brand.

03 october 2024
Received FDA approval for "NeuroFlex," a revolutionary drug for managing early-stage Alzheimer’s disease, offering patients hope for slowing cognitive decline and improving quality of life.

16 November 2024
Renamed to "Hauser Pharmaceuticals" to reflect its broader mission in modern medicine, symbolizing its transition from herbal remedies to a global pharmaceutical leader.

28 December 2024
Opened its first manufacturing plant in the United States to meet growing demand, marking a significant milestone in its expansion strategy and operational capabilities.

28 December 2024
Expanded into cancer research, establishing a dedicated oncology division and making substantial progress in developing innovative treatments for various types of cancer.

03 october 2024
Ranked among the top 10 pharmaceutical companies worldwide based on revenue, driven by consistent innovation, a strong research pipeline, and an expanding global footprint.

16 November 2024
Launched a global initiative for affordable access to essential medicines in developing countries, providing life-saving drugs to millions and earning recognition for corporate social responsibility.

03 october 2024
Launched a global initiative for affordable access to essential medicines in developing countries, providing life-saving drugs to millions and earning recognition for corporate social responsibility.

16 November 2024
Developed and patented "ImmunoPro," a groundbreaking vaccine for a rare autoimmune disorder, becoming a pioneer in addressing unmet medical needs for niche diseases.

28 December 2024
Acquired BioGenix, a biotechnology company specializing in gene therapy research, paving the way for cutting-edge treatments and expanding its research capabilities.

03 october 2024
Lorem ipsum dolor sit amet, consectetur adipisicing elit. At consequuntur delectus explicabo labore nihil officia optio repudiandae similique soluta! Aliquam corporis cum delectus inventore. Debitis laborum libero nesciunt quisquam repellendus. Lorem ipsum dolor sit amet, consectetur adipisicing elit. At consequuntur delectus explicabo labore nihil officia optio repudiandae similique soluta! Aliquam corporis cum delectus inventore. Debitis laborum libero nesciunt quisquam repellendus.